All this happening and the license negotiations for ROW LANI now underway for at least a couple of months. I'm greatly looking forward to the license announcement, it's the most perfect scenario for licensing the drug that I can possibly imagine.
BTA Price at posting:
$2.93 Sentiment: Buy Disclosure: Held